Table 2.
Analysis clinical characteristics of the AMI group and non-MI group (non-MI)
| Variables | AMI group (n = 40) | Non-MI group (n = 44) | p-value |
|---|---|---|---|
| Male/female (n/n) | 30/10 | 24/20 | 0.097a |
| Age (years) | 55.65 ± 11.36 | 56.86 ± 12.15 | 0.638b |
| BMI (kg/m2) | 26.19 ± 3.65 | 26.03 ± 3.52 | 0.579c |
| Smoking history (%) | 75.00% | 54.50% | 0.051a |
| Hypertension (%) | 75.00% | 54.50% | 0.051a |
| SBP (mmHg) | 158.18 ± 23.43 | 153.20 ± 34.12 | 0.201c |
| DBP (mmHg) | 87.83 ± 15.62 | 86.52 ± 17.49 | 0.615c |
| Diabetes (%) | 30.00% | 18.18% | 0.204a |
| Killip class at admission ≥ II (%) | 7.50% | 0 | 0.064a |
| TC (mmol/L) | 4.76 ± 0.93 | 4.48 ± 1.25 | 0.018c |
| TG (mmol/L) | 1.90 ± 1.48 | 1.86 ± 1.14 | 0.622c |
| LDL (mmol/L) | 2.84 ± 0.92 | 2.44 ± 0.81 | 0.038b |
| HDL (mmol/L) | 1.06 ± 0.28 | 1.12 ± 0.30 | 0.361c |
| GLU (mmol/L) | 9.25 ± 4.47 | 6.49 ± 1.97 | 0.00c |
| WBC (× 109/L) | 11.68 ± 2.88 | 6.80 ± 2.15 | 0.000c |
| PLT (109/L) | 235.35 ± 52.79 | 238.20 ± 58.06 | 0.670c |
| Cr (µmol/L) | 61.07 ± 16.13 | 63.36 ± 11.29 | 0.457b |
| CK-MB (U/L) | 150.42 ± 156.42 | 14.85 ± 21.45 | 0.000c |
| cTnI (ng/mL) | 12.28 ± 12.29 | 0.06 ± 0.05 | 0.000c |
| M (× 109/L) | 0.55 ± 0.25 | 0.42 ± 0.19 | 0.003c |
| L (× 109/L) | 1.83 ± 1.09 | 2.05 ± 0.55 | 0.021c |
| N (× 109/L) | 8.88 ± 3.11 | 4.16 ± 2.79 | 0.000c |
aChi-squared test
bStudent’s t test
cMann–Whitney U test